Fabien Maldonado, Professor of Medicine and Thoracic Surgery, Director, Vanderbilt University Interventional Pulmonology Section, shared on LinkedIn:
“How should we approach the future of lung cancer screening? Join us for the inaugural Vanderbilt Thoracic Oncology Debate on Friday, December 4, 2026, from noon to 1 p.m. CT, available both in person at Light Hall in Nashville, Tennessee, and via livestream.
Nationally recognized thoracic oncology leaders Dr. Ankit Bharat at of Northwestern Medicine and Dr. Gerard Silvestri of the Medical University of South Carolina will debate a critical question in lung cancer prevention: Should lung cancer screening be offered universally based on age, rather than limited to individuals who meet current risk-based eligibility criteria?
Through an evidence-based discussion, attendees will hear contrasting perspectives on the potential impact of expanded screening, including early detection, screening disparities, overdiagnosis, and healthcare resource utilization. The program will also include rebuttals and audience discussion.
We invite clinicians, researchers, trainees, and anyone interested in the future of lung cancer prevention and early detection to join this important conversation.
You can also read: What Changes in Lung Oncology After ESMO 2026? Survival Breakthroughs, ADC Competition, and a New Era of Precision Treatment
